These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29127534)

  • 21. Frequency and predictors for late start of antiretroviral therapy in primary care clinics, Kampala, Uganda.
    Sendagire I; Cobelens F; Kambugu A; Konde-Lule J; van der Loeff MS
    J Acquir Immune Defic Syndr; 2012 Nov; 61(3):e33-9. PubMed ID: 22820807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiretroviral therapy initiation and outcomes of hospitalized HIV-infected patients in Uganda-An evaluation of the HIV test and treat strategy.
    Katende A; Nakiyingi L; Andia-Biraro I; Katairo T; Muhumuza R; Ssemata AS; Nsereko C; Semitala FC; Meya DB
    PLoS One; 2022; 17(8):e0268122. PubMed ID: 35984779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda.
    Kipp W; Alibhai A; Saunders LD; Senthilselvan A; Kaler A; Konde-Lule J; Okech-Ojony J; Rubaale T
    AIDS Care; 2010 Mar; 22(3):271-8. PubMed ID: 20390506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High burden of previously undiagnosed HIV infections and gaps in HIV care cascade for conflict-affected female sex workers in northern Uganda.
    Goldenberg SM; Muzaaya G; Akello M; Braschel M; Birungi J; Shannon K
    Int J STD AIDS; 2019 Mar; 30(3):275-283. PubMed ID: 30417750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High viral suppression and low attrition in healthy HIV-infected patients initiated on ART with CD4 above 500 cells/µL in a program setting in Uganda.
    Byonanebye DM; Semitala FC; Katende J; Bakenga A; Arinaitwe I; Kyambadde P; Musinguzi P; Biraro IA; Byakika-Kibwika P; Kamya MR
    Afr Health Sci; 2020 Mar; 20(1):132-141. PubMed ID: 33402901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with long-term antiretroviral therapy attrition among adolescents in rural Uganda: a retrospective study.
    Okoboi S; Ssali L; Yansaneh AI; Bakanda C; Birungi J; Nantume S; Okullu JL; Sharp AR; Moore DM; Kalibala S
    J Int AIDS Soc; 2016; 19(5 Suppl 4):20841. PubMed ID: 27443271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risky sexual behavior among patients on long-term antiretroviral therapy: a prospective cohort study in urban and rural Uganda.
    Okoboi S; Castelnuovo B; Moore DM; Musaazi J; Kambugu A; Birungi J; Kaleebu P; Nanfuka M; Kamya MR; Van Rie A
    AIDS Res Ther; 2018 Oct; 15(1):15. PubMed ID: 30340608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlates of ART Use Among Newly Diagnosed HIV Positive Adolescent Girls and Young Women Enrolled in HPTN 068.
    Filiatreau LM; Wright M; Kimaru L; Gómez-Olivé FX; Selin A; Twine R; Kahn K; Pettifor A
    AIDS Behav; 2020 Sep; 24(9):2606-2615. PubMed ID: 32110814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of undetectable and suppressed viral load in HIV-infected pregnant women initiating Option B+ in Uganda: an observational study nested within a randomized controlled trial.
    Gabagaya G; Rukundo G; Amone A; Wavamunno P; Namale-Matovu J; Lubega I; Nakabiito C; Namukwaya Z; Nolan M; Malamba SS; King R; Homsy J; Fowler MG; Musoke P
    BMC Infect Dis; 2021 Sep; 21(1):907. PubMed ID: 34481464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concomitant herbal medicine and Antiretroviral Therapy (ART) use among HIV patients in Western Uganda: a cross-sectional analysis of magnitude and patterns of use, associated factors and impact on ART adherence.
    Lubinga SJ; Kintu A; Atuhaire J; Asiimwe S
    AIDS Care; 2012; 24(11):1375-83. PubMed ID: 22292937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human immunodeficiency virus care cascade among sub-populations in Rakai, Uganda: an observational study.
    Billioux VG; Chang LW; Reynolds SJ; Nakigozi G; Ssekasanvu J; Grabowski MK; Ssekubugu R; Nalugoda F; Kigozi G; Kagaayi J; Serwadda D; Gray RH; Wawer MJ
    J Int AIDS Soc; 2017 Jun; 20(1):21590. PubMed ID: 28605171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV and other sexually transmitted infections in a cohort of women involved in high-risk sexual behavior in Kampala, Uganda.
    Vandepitte J; Bukenya J; Weiss HA; Nakubulwa S; Francis SC; Hughes P; Hayes R; Grosskurth H
    Sex Transm Dis; 2011 Apr; 38(4):316-23. PubMed ID: 23330152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent levels and trends in HIV incidence rates among adolescent girls and young women in ten high-prevalence African countries: a systematic review and meta-analysis.
    Birdthistle I; Tanton C; Tomita A; de Graaf K; Schaffnit SB; Tanser F; Slaymaker E
    Lancet Glob Health; 2019 Nov; 7(11):e1521-e1540. PubMed ID: 31607465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors predictive of successful retention in care among HIV-infected men in a universal test-and-treat setting in Uganda and Kenya: A mixed methods analysis.
    Brown LB; Getahun M; Ayieko J; Kwarisiima D; Owaraganise A; Atukunda M; Olilo W; Clark T; Bukusi EA; Cohen CR; Kamya MR; Petersen ML; Charlebois ED; Havlir DV; Camlin CS
    PLoS One; 2019; 14(1):e0210126. PubMed ID: 30673744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi.
    Brown JP; Ngwira B; Tafatatha T; Crampin AC; French N; Koole O
    AIDS Res Ther; 2016; 13():24. PubMed ID: 27398087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries.
    Lahuerta M; Wu Y; Hoffman S; Elul B; Kulkarni SG; Remien RH; Nuwagaba-Biribonwoha H; El-Sadr W; Nash D; ;
    Clin Infect Dis; 2014 Feb; 58(3):432-41. PubMed ID: 24198226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ART adherence and viral suppression are high among most non-pregnant individuals with early-stage, asymptomatic HIV infection: an observational study from Uganda and South Africa.
    Haberer JE; Bwana BM; Orrell C; Asiimwe S; Amanyire G; Musinguzi N; Siedner MJ; Matthews LT; Tsai AC; Katz IT; Bell K; Kembabazi A; Mugisha S; Kibirige V; Cross A; Kelly N; Hedt-Gauthier B; Bangsberg DR
    J Int AIDS Soc; 2019 Feb; 22(2):e25232. PubMed ID: 30746898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017.
    Ngongo NM; Darcis G; Nanituna HS; Mambimbi MM; Maes N; Mashi ML; Bepouka Izizag B; Moutschen M; Lepira Bompeka F
    PLoS One; 2021; 16(11):e0259073. PubMed ID: 34739506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.
    Hermans SM; Kiragga AN; Schaefer P; Kambugu A; Hoepelman AI; Manabe YC
    PLoS One; 2010 May; 5(5):e10527. PubMed ID: 20479873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.